The present study investigated reward and motor function in the Fmr1-/Y mouse model of fragile X syndrome (FXS) by measuring the sensitivity of brain stimulation reward (BSR) and locomotor activity, respectively, to drugs that affect dopamine, muscarinic acetylcholine, and metabotropic glutamate receptors. This evidence concerns the gene FMR1 and fragile X syndrome.